Israel vs Mexico: Cause of death, by non-communicable diseases, ages 5-14, male
Israel
52.3%
in 2021
Mexico
51.7%
in 2021
Israel rank
46th
Mexico rank
48th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Israel
- Mexico
How they compare
Israel currently reports 52.3% against 51.7% in Mexico, a difference of 0.6%.
Across all 6 years both countries report, Israel has been ahead every year.
Israel ranks 46th and Mexico ranks 48th of 185 countries.
Israel has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Israel | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 52.2% | 40.3% | 12.0% | Israel |
| 2010s | 61.9% | 50.5% | 11.4% | Israel |
| 2020s | 56.1% | 51.8% | 4.3% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Israel or Mexico?
- Israel, at 52.3% against 51.7% in Mexico as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Israel and Mexico?
- 0.6%, with Israel ahead.
- How many years of comparable data are there for Israel and Mexico?
- 6 years are reported by both, from 2000 to 2021.
- How do Israel and Mexico rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Israel ranks 46th and Mexico ranks 48th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.